Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection
Authors:
Open Access
- 18 June 2013
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 32 (12) , 1517-1523
Abstract
We evaluated blood and fecal biomarkers as indicators of severity in symptomatic patients with confirmed Clostridium difficile infection (CDI). Recruitment included patients with CDI based on clinical symptoms and supporting laboratory findings. Disease severity was defined by physician’s assessment and blood and fecal biomarkers were measured. Toxigenic culture done using spore enrichment and toxin B detected by tissue culture were done as confirmatory tests. Polymerase chain reaction (PCR) ribotyping was performed on each isolate. There were 98 patients recruited, with 85 (87 %) confirmed cases of toxigenic CDI (21 severe, 57 moderate, and seven mild), of which 68 (80 %) were also stool toxin-positive. Elevated lactoferrin (p = 0.01), increased white blood cell (WBC) count (p = 0.08), and low serum albumin (p = 0.03) were all associated with the more severe cases of CDI. Ribotype 027 infection accounted for 71 % of severe cases (p < 0.01) and patients with stool toxin had significantly higher lactoferrin levels and WBC counts (p < 0.05). Our findings show that elevated fecal lactoferrin, along with increased WBC count and low serum albumin, were associated with more severe CDI. In addition, patients infected with ribotype 027 and those with stool toxin had significantly higher fecal lactoferrin and WBC counts.Keywords
This publication has 38 references indexed in Scilit:
- Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial ManagementClinical Infectious Diseases, 2012
- Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistencyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Diarrhea, Clostridium difficile, and Intestinal Inflammation in Residents of a Long-Term Care FacilityJournal of the American Medical Directors Association, 2010
- Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficileJournal of Hospital Infection, 2009
- Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case StudyPLOS ONE, 2008
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027Emerging Infectious Diseases, 2007
- Clostridium difficile –associated Disease in New Jersey Hospitals, 2000–20041Emerging Infectious Diseases, 2007
- Fecal Lactoferrin Is A Sensitive and Specific Marker in Identifying Intestinal InflammationAmerican Journal of Gastroenterology, 2003
- Stool Form Scale as a Useful Guide to Intestinal Transit TimeScandinavian Journal of Gastroenterology, 1997